Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
P 1 (1)
P 2 (3)
P 3 (2)

Trial Status

Recruiting3
Not Yet Recruiting2
Active Not Recruiting1
Enrolling By Invitation1

Clinical Trials (7)

Showing 7 of 7 trials
NCT06678074Phase 1Active Not Recruiting

Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI

NCT07362446Phase 2Not Yet Recruiting

Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

NCT07380919Phase 2RecruitingPrimary

Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study

NCT07257198Phase 3Recruiting

Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

NCT07229248Phase 3RecruitingPrimary

DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial

NCT06935383Phase 2Not Yet RecruitingPrimary

Randomised EValuation of Therapies for microvAscuLar Injury in STEACS

NCT06763549Enrolling By Invitation

COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

Showing all 7 trials

Research Network

Activity Timeline